Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

被引:25
|
作者
Lee, M. R. [1 ]
Jayant, R. D. [2 ]
机构
[1] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Bethesda, MD 20892 USA
[2] Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Amarillo, TX 79106 USA
基金
美国国家卫生研究院;
关键词
Neuropeptides; Oxytocin; Blood-brain barrier (BBB); Receptor mediated transcytosis (RMT); CRISPR/Cas9-gRNA; CARRIER-MEDIATED TRANSPORT; DRUG-DELIVERY; CEREBROSPINAL-FLUID; GENE-EXPRESSION; OXYTOCIN; NANOPARTICLES; PEPTIDES; VASOPRESSIN; PASSAGE; SYSTEMS;
D O I
10.1007/s00441-018-2959-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The blood-brain barrier (BBB) is a structural and functional barrier between the interstitial fluid of the brain and the blood; the barrier maintains the precisely controlled biochemical environment that is necessary for neural function. This constellation of endothelial cells, macrophages, pericytes, and astrocytes forms the neurovascular unit which is the structural and functional unit of the blood-brain barrier. Peptides enter and exit the CNS by transport systems expressed by the capillary endothelial cells of the neurovascular unit. Limiting the transport of peptides and proteins into the brain are efflux transporters like P-gp are transmembrane proteins present on the luminal side of the cerebral capillary endothelium and their function is to promote transit and excretion of drugs from the brain to the blood. Nanocarrier systems have been developed to exploit transport systems for enhanced BBB transport. Recent approaches for enhancing endogenous peptide expression are discussed.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 50 条
  • [41] Efflux transport systems at the blood-brain barrier and blood CSF barrier
    Kusuhara, H
    Sugiyama, Y
    DRUG TRANSPORT(ERS) AND THE DISEASED BRAIN, 2005, 1277 : 111 - 122
  • [42] TRANSPORT CHARACTERISTICS OF TRAMADOL AT THE BLOOD-BRAIN BARRIER
    Deguchi, Yoshiharu
    Kitamura, Atsushi
    Higuchi, Kei
    Okura, Takashi
    DRUG METABOLISM REVIEWS, 2015, 47 : 291 - 291
  • [43] BLOOD-BRAIN BARRIER TRANSPORT OF VALPROIC ACID
    CORNFORD, EM
    DIEP, CP
    PARDRIDGE, WM
    JOURNAL OF NEUROCHEMISTRY, 1985, 44 (05) : 1541 - 1550
  • [44] Transport Characteristics of Tramadol in the Blood-Brain Barrier
    Kitamura, Atsushi
    Higuchi, Kei
    Okura, Takashi
    Deguchi, Yoshiharu
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (10) : 3335 - 3341
  • [45] In situ blood-brain barrier transport of nanoparticles
    Koziara, JM
    Lockman, PR
    Allen, DD
    Mumper, RJ
    PHARMACEUTICAL RESEARCH, 2003, 20 (11) : 1772 - 1778
  • [46] Glutathione transport by the blood-brain barrier.
    Peterson, DR
    Rambow, J
    Sukowski, EJ
    Zikos, D
    FASEB JOURNAL, 1999, 13 (05): : A709 - A709
  • [47] Blood-brain barrier transport of drugs - Discussion
    de Boer, AG
    Tsuji, A
    Pardridge, WM
    Smith, Q
    Abbott, J
    Fenstermacher, JD
    Begley, D
    Drewes, LR
    Betz, AL
    Anderson, BD
    BRAIN BARRIER SYSTEMS, 1999, 45 : 454 - 458
  • [48] Deltorphin transport across the blood-brain barrier
    Fiori, A
    Cardelli, P
    Negri, L
    Savi, MR
    Strom, R
    Erspamer, V
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) : 9469 - 9474
  • [49] Targeted transport of biotherapeutics at the blood-brain barrier
    Moos, Torben
    Thomsen, Maj Schneider
    Burkhart, Annette
    Hede, Eva
    Laczek, Bartosz
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (12) : 1823 - 1838
  • [50] Plasticity of Carbohydrate Transport at the Blood-Brain Barrier
    McMullen, Ellen
    Weiler, Astrid
    Becker, Holger M.
    Schirmeier, Stefanie
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2021, 14